| For: | Bramanti SM, Trumello C, Lombardi L, Cavallo A, Stuppia L, Antonucci I, Babore A. Uncertainty following an inconclusive result from the BRCA1/2 genetic test: A review about psychological outcomes. World J Psychiatr 2021; 11(5): 189-200 [PMID: 34046315 DOI: 10.5498/wjp.v11.i5.189] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v11/i5/189.htm |
| Number | Citing Articles |
| 1 |
Gabriella C. Torretto, Matthew D. Martin, Kaamraan Islam, Nicole E. Archer, Harriet E. Feilotter, Scott K. Davey. Domain-Specific Computational, Functional and Structural Methods Enable Interpretation of BRCA1 BRCT Variants of Uncertain Significance. Current Oncology 2026; 33(6) doi: 10.3390/curroncol33060354
|
| 2 |
Kate E Dibble, Laura K.M. Donorfio, Preston A Britner, Keith M Bellizzi. Stress, anxiety, and health-related quality of life in BRCA1/2-positive women with and without cancer: A comparison of four US female samples. Gynecologic Oncology Reports 2022; 42 doi: 10.1016/j.gore.2022.101033
|
| 3 |
Brian J. Shayota. Downstream Assays for Variant Resolution. Pediatric Clinics of North America 2023; 70(5) doi: 10.1016/j.pcl.2023.05.006
|
| 4 |
Tomoko Watanabe, Kaori Kimura, Minako Kakimoto, Yumie Hiraoka, Manami Matsukawa, Hiroko Nagahashi, Saki Horiguchi, Miwa Toshima, Chikako Tomozawa, Miki Aitani, Takeshi Kuwata, Teruhiko Yoshida, Makoto Hirata, Noriko Tanabe. Reliability and validity of the multidimensional impact of cancer risk assessment (MICRA) questionnaire: Japanese version. Familial Cancer 2025; 24(3) doi: 10.1007/s10689-025-00496-2
|
| 5 |
Lucrezia Pilenzi, Federico Anaclerio, Anastasia Dell’Elice, Maria Minelli, Roberta Giansante, Michela Cicirelli, Nicola Tinari, Antonino Grassadonia, Andrea Pantalone, Simona Grossi, Nicole Canale, Annalisa Bruno, Giuseppe Calabrese, Patrizia Ballerini, Liborio Stuppia, Ivana Antonucci. The Crucial Role of Hereditary Cancer Panel Testing in Unaffected Individuals with a Strong Family History of Cancer: A Retrospective Study of a Cohort of 103 Healthy Subjects. Cancers 2024; 16(13) doi: 10.3390/cancers16132327
|
| 6 |
Megan Best, Christine Napier, Timothy Schlub, Nicci Bartley, Barbara Biesecker, Mandy Ballinger, Phyllis Butow. Validation of the multidimensional impact of Cancer Risk Assessment Questionnaire to assess impact of waiting for genome sequencing results. Psycho-Oncology 2022; 31(7) doi: 10.1002/pon.5908
|
| 7 |
Lucia Lombardi, Carmen Trumello, Liborio Stuppia, Ivana Antonucci, Tânia Brandão, Alessandra Babore. BRCA1/2 pathogenetic variant carriers and reproductive decisions: Gender differences and factors associated with the choice of preimplantation genetic diagnosis (PGD) and prenatal diagnosis (PND). Journal of Assisted Reproduction and Genetics 2022; 39(7) doi: 10.1007/s10815-022-02523-y
|
| 8 |
Sara Di Rado, Roberta Giansante, Michela Cicirelli, Lucrezia Pilenzi, Anastasia Dell’Elice, Federico Anaclerio, Martina Rimoldi, Antonino Grassadonia, Simona Grossi, Nicole Canale, Patrizia Ballerini, Liborio Stuppia, Ivana Antonucci. Detection of Germline Mutations in a Cohort of 250 Relatives of Mutation Carriers in Multigene Panel: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2. Cancers 2023; 15(24) doi: 10.3390/cancers15245730
|
| 9 |
Deborah Cragun, Marleah Dean, David Baker, Meghan Kelley, Gillian Hooker, Anne Weidner, Paige Hunt, Tuya Pal. The Development and Evaluation of Novel Patient Educational Material for a Variant of Uncertain Significance (VUS) Result in Hereditary Cancer Genes. Current Oncology 2024; 31(6) doi: 10.3390/curroncol31060256
|